Significant advances in cellular reprogramming have facilitated the directed differentiation of islet beta cells from a variety of pluripotent cell populations. Furthermore, discovery of the previously unappreciated plasticity in adult islet cell populations has led to many studies demonstrating transdifferentiation/reprogramming of mature non-beta islet cell populations into beta cells, and vice versa. However, the downside of this innate islet cell plasticity is that these cells also display inherent phenotypic instability. As such, there is growing evidence in rodent and human islets for spontaneous reprogramming of beta cells in pathophysiological conditions that can lead to loss of cellular identity, phenotypic dysfunction and ultimately diabetes. In light of these advances and discoveries, the questions have shifted from ?can we generate new sources of beta cells?? to ?can a functional beta cell phenotype be maintained?? and ?what are the transcriptional mechanisms and epigenetic landscapes that distinguish beta cells from the other islet populations??. Our studies have demonstrated that Nkx2.2 is a critical regulator of the specification and differentiation of several defined islet cell populations in mice and humans. We also determined that Nkx2.2 is critical for the maintenance of a functional beta cell phenotype; deletion of Nkx2.2 in the beta cell causes reprogramming of beta cells to alpha, delta and PP cells. Importantly, Nkx2.2 function is required continuously throughout life to directly activate key beta cell genes, such as MafA and NeuroD1, and directly repress non-beta cell master regulator genes, such as Arx and MafB (alpha cells) and Hhex (delta cells). Nkx2.2 repressor functions are at least partially mediated through interactions with the corepressor protein Grg3/TLE3, the predominant groucho family member expressed in the islet. Since Nkx2.2 and Grg3 are also highly expressed in alpha cells, where they presumably do not repress alpha cell genes, comparative analysis of Nkx2.2/Grg activity in the two islet cell populations will provide insight into the regulation of the alpha cell versus beta cell transcriptional and epigenetic programs. We hypothesize that Nkx2.2 recruits distinct transcriptional complexes ? with and without Grg3 - to the same genes in alpha versus beta cells. The goal of this application is to further dissect the Nkx2.2-mediated regulatory and epigenetic events that are essential for alpha versus beta cell identities and functions. This study will provide important new knowledge about the molecular mechanisms that regulate islet cell differentiation and identity that will 1) inform the directed differentiation of alpha versus beta cells; 2) identify the transcriptional programs that are important in the reprogramming of alpha cells to beta cells; and 3) determine the epigenetic landscapes that must be established to ensure the maintenance of distinct islet cell phenotypes in pathophysiological conditions.

Public Health Relevance

The pancreatic islet plays a critical role in the regulation of glucose metabolism. Advances in pluripotent stem cell-derived beta cells and the discovery that significant plasticity exists in adult islet populations have emphasized the importance understanding the transcriptional programs that define each islet cell type and the molecular mechanisms that are required to maintain individual functional cellular phenotypes. The studies proposed in this grant will characterize the primary transcriptional and epigenetic pathways that distinguish alpha and beta cells, and contribute to the maintenance of their functional phenotypes in physiological and pathophysiological conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK082590-12
Application #
9949701
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Sato, Sheryl M
Project Start
2009-08-01
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
12
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Pediatrics
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Singer, Ruth A; Sussel, Lori (2018) Islet Long Noncoding RNAs: A Playbook for Discovery and Characterization. Diabetes 67:1461-1470
Font-Cunill, Berta; Arnes, Luis; Ferrer, Jorge et al. (2018) Long Non-coding RNAs as Local Regulators of Pancreatic Islet Transcription Factor Genes. Front Genet 9:524
Gutierrez, Giselle Dominguez; Gromada, Jesper; Sussel, Lori (2017) Heterogeneity of the Pancreatic Beta Cell. Front Genet 8:22
Ediger, Benjamin N; Lim, Hee-Woong; Juliana, Christine et al. (2017) LIM domain-binding 1 maintains the terminally differentiated state of pancreatic ? cells. J Clin Invest 127:215-229
Churchill, Angela J; Gutiérrez, Giselle Dominguez; Singer, Ruth A et al. (2017) Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development. Elife 6:
Gutiérrez, Giselle Domínguez; Bender, Aaron S; Cirulli, Vincenzo et al. (2017) Pancreatic ? cell identity requires continual repression of non-? cell programs. J Clin Invest 127:244-259
Gross, Stefanie; Garofalo, Diana C; Balderes, Dina A et al. (2016) The novel enterochromaffin marker Lmx1a regulates serotonin biosynthesis in enteroendocrine cell lineages downstream of Nkx2.2. Development 143:2616-28
Arnes, Luis; Akerman, Ildem; Balderes, Dina A et al. (2016) ?linc1 encodes a long noncoding RNA that regulates islet ?-cell formation and function. Genes Dev 30:502-7
Gross, Stefanie; Balderes, Dina; Liu, Jing et al. (2015) Nkx2.2 is expressed in a subset of enteroendocrine cells with expanded lineage potential. Am J Physiol Gastrointest Liver Physiol 309:G975-87
Müller, T D; Nogueiras, R; Andermann, M L et al. (2015) Ghrelin. Mol Metab 4:437-60

Showing the most recent 10 out of 36 publications